Expired Tender USA ICB TOT Ref. 143217266

Contact Activation Pathway Function Blocking Tender - 143217266

Tender notice from USA, published on 12 Jun 2026.

Executive Summary

The ITY-RESULT _NGCONTENT-NG-C92264979="" _NGHOST-NG-C893956049="" CLASS="NG-STAR-INSERTED" CONTACT ACTIVATION PATHWAY FUNCTION BLOCKING ANTIBODY AB023 has issued a Tender notice for the procurement of a Contact Activation Pathway Function Blocking Antibody Ab023 in the USA. This Tender notice was published on 12 Jun 2026 and is scheduled to close on 18 Jun 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 143217266, while the tender notice number is HT9426-26-RFI-WS03 and Register on the platform.

Key facts

Summary
Contact Activation Pathway Function Blocking Antibody Ab023
TOT Ref. No.
143217266
Document Ref. No.
HT9426-26-RFI-WS03
Country
USA
Notice type
Tender
Competition
ICB
Publication date
12 Jun 2026
Bid deadline
18 Jun 2026
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Request for Information Notice HT9426-26-RFI-WS03 for Contact Activation Pathway Function Blocking Antibody AB023
This is a REQUEST FOR INFORMATION (RFI) ANNOUNCEMENT ONLY. It is neither a solicitation announcement nor a request for proposals or quotes and does not obligate the Government to award a contract. Requests for a solicitation will not receive a response. Responses to this RFI must be in writing.
The purpose of this RFI announcement is to conduct market research to make appropriate acquisition decisions and to gain knowledge of potential qualified offerors interested and capable of providing the contact activation pathway function blocking antibody AB023 described below. Documentation of technical expertise must be presented in sufficient detail for the Government to determine that your company possesses the necessary functional area of expertise and experience to compete for the acquisition.
The Defense Health Agency (DHA), Defense Health Agency Contracting Activity (DHACA), 808 Schreider Street, Fort Detrick, MD 21702, is seeking potential qualified offerors to provide contact activation pathway function blocking antibody AB023:
Coagulation Factor XI (FXI) Inhibitor AB023 (Xisomab 3G3 / Gruticibart)
Shall target specific blood clotting factors without increasing the risk of bleeding
Shall bind to the "apple 2" domain of FXI, inhibiting its activation by activated factor XII (FXIIa) in the "contact pathway" which drives clot formation in artificial surfaces
Shall be designed for use in Extracorporeal Membrane Oxygenation (ECMO) circuits, hemodialysis, catheters, and cancer-related thrombosis
Shall preserve natural clotting (hemostasis)
Shall not block the activation of FXI by thrombin
Shall not block the conversion of Factor IX by activated Factor XI (FXIa), which allows it to preserve the necessary hemostatic function of FXI activation by thrombin required for normal wound healing
Shall provide a maximum...
Notice ID: ht9426-26-rfi-ws03

Department/Ind. Agency: dept of defense

Sub-tier: defense health agency (dha)

Office: defense health agency

Product Service Code: 6505 - drugs and biologicals

NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Inactive Dates: jul 03, 2026

Inactive Policy: 15 days after response date

Documents

Tender Notice
Login to view

Corresponding contract award notice

USA Public Procurement Intelligence

Frequently asked questions

The bid deadline for Contact Activation Pathway Function Blocking Antibody Ab023 was 18 Jun 2026. Bidding is closed.

This tender has been issued by ITY-RESULT _NGCONTENT-NG-C92264979="" _NGHOST-NG-C893956049="" CLASS="NG-STAR-INSERTED" CONTACT ACTIVATION PATHWAY FUNCTION BLOCKING ANTIBODY AB023 in USA.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 143217266. The purchaser document reference is HT9426-26-RFI-WS03.

Browse other tenders from USA or search by relevant keywords and CPV classification.